Achiko AG provided updates on test performance. Test Performance: As the Company is proceeding to sales and is currently going through external validation, the Company reported that early results indicate a strong performance against other forms of testing. Unlike molecular and immunoassay approaches, the test's use of DNA aptamers has yielded encouraging results at low viral loads outperforming most lateral flow based rapid tests.

This is particularly important as early detection provides communities the opportunity to better manage and minimise the spread of the virus, treat the affected population more effectively, and limit adverse effects on economies and people's livelihood.